SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

The investigation concerns whether PetMed and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. On June 11, 2024, PetMed issued a press release announcing its financial results for its fourth quarter and fiscal year 2024. Among other items, PetMed reported a net loss per share of $0.25, compared to a net loss per share of $0.01 in the year-ago period. Although PetMed reported a net increase in sales year over year, that was outweighed by an incre ...